S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$227.55
-1.1%
$253.64
$161.65
$275.00
$11.72B1.4550,575 shs707,817 shs
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
$354.53
$244.57
$394.99
$13.80B0.6345,684 shs406,900 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
-1.02%-7.66%-14.62%+7.32%+12.17%
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
0.00%0.00%0.00%0.00%-6.16%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
4.8844 of 5 stars
3.34.00.04.74.02.52.5
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
4.2838 of 5 stars
3.70.02.51.91.11.74.4

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
2.64
Moderate Buy$253.2311.29% Upside
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
3.33
Buy$432.50∞ Upside

Current Analyst Ratings

Latest SHOE, RE, SWL, RM2, and CRL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/18/2024
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$240.00 ➝ $290.00
2/15/2024
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$260.00 ➝ $265.00
2/15/2024
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$215.00 ➝ $250.00
2/15/2024
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$270.00 ➝ $290.00
2/15/2024
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$270.00 ➝ $280.00
2/15/2024
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$252.00 ➝ $268.00
2/15/2024
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$4.13B2.84$16.47 per share13.82$70.15 per share3.24
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
$12.06B0.00N/A12.28$215.52 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$474.62M$9.2124.7118.401.8211.49%16.53%7.02%5/9/2024 (Confirmed)
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
$597M$16.8620.840.000.285.34%12.98%2.79%N/A

Latest SHOE, RE, SWL, RM2, and CRL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$2.05N/A-$2.05N/AN/AN/A  
2/14/2024Q4 2023
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$2.39$2.46+$0.07$1.30$991.25 million$1.01 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
N/AN/AN/AN/AN/A
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
$6.60N/AN/A39.15%1 Years

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
0.73
1.52
1.16
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
0.34
0.33
0.33

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
98.91%
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
94.39%

Insider Ownership

CompanyInsider Ownership
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
1.30%
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
1.40%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
21,80051.51 million50.84 millionOptionable
Everest Re Group, Ltd. stock logo
RE
Everest Re Group
2,42839.28 million38.73 millionOptionable

SHOE, RE, SWL, RM2, and CRL Headlines

SourceHeadline
The Everest Industrial Complex, DeconstructedThe Everest Industrial Complex, Deconstructed
msn.com - April 17 at 1:52 PM
Everest Group Signs 66,444 SF Office Lease at 1155 Avenue of the Americas in ManhattanEverest Group Signs 66,444 SF Office Lease at 1155 Avenue of the Americas in Manhattan
rebusinessonline.com - April 17 at 1:52 PM
AIG’s David Ho joins Everest Insurance Intl. as Head of Financial Lines, AsiaAIG’s David Ho joins Everest Insurance Intl. as Head of Financial Lines, Asia
reinsurancene.ws - April 17 at 7:51 AM
LogicSource Named as One of Americas Fastest Growing Companies by Financial TimesLogicSource Named as One of America's Fastest Growing Companies by Financial Times
finance.yahoo.com - April 16 at 4:04 PM
Reinsurance Market Gears Up for 4.5% CAGR Rise, Aiming at US$ 474 Billion by 2032Reinsurance Market Gears Up for 4.5% CAGR Rise, Aiming at US$ 474 Billion by 2032
fmiblog.com - April 16 at 4:04 PM
Deals of the Day: April 16Deals of the Day: April 16
crainsnewyork.com - April 16 at 4:04 PM
Excerpt: What Jon Krakauer’s “Into Thin Air” Got Wrong About EverestExcerpt: What Jon Krakauer’s “Into Thin Air” Got Wrong About Everest
msn.com - April 16 at 4:04 PM
Everest Climbs Delayed: What’s Going On With The Khumbu icefall?Everest Climbs Delayed: What’s Going On With The Khumbu icefall?
msn.com - April 16 at 4:04 PM
Everest Moving to 66K SF at 1155 Avenue of the AmericasEverest Moving to 66K SF at 1155 Avenue of the Americas
commercialobserver.com - April 16 at 4:04 PM
The EPA is ignoring cancer-causing polluters againThe EPA is ignoring cancer-causing polluters again
mlive.com - April 13 at 7:25 AM
Using Kindness To Change Someone’s MindUsing Kindness To Change Someone’s Mind
yahoo.com - April 12 at 11:17 AM
The Week in 90 Seconds: Lloyd’s top performers, Cargo rates, European loss creepThe Week in 90 Seconds: Lloyd’s top performers, Cargo rates, European loss creep
insuranceinsider.com - April 12 at 11:17 AM
The Evolution of Mount Everest Ascents: A Historical and Statistical Analysis of Climbing TriumphsThe Evolution of Mount Everest Ascents: A Historical and Statistical Analysis of Climbing Triumphs
msn.com - April 9 at 11:43 PM
Everest Reinsurance COO on key challenges facing todays reinsurance marketEverest Reinsurance COO on key challenges facing today's reinsurance market
insurancebusinessmag.com - April 9 at 1:42 PM
Outgoing Wipro CEO Delaporte found it tough to win hearts and minds of traditional Indian IT firmOutgoing Wipro CEO Delaporte 'found it tough to win hearts and minds of traditional Indian IT firm'
msn.com - April 8 at 1:45 PM
Lancashire Insurance expands global footprint with opening of US businessLancashire Insurance expands global footprint with opening of US business
reinsurancene.ws - April 8 at 8:45 AM
An Electric Motorcycle Team Attempted the Brutal San Felipe 250An Electric Motorcycle Team Attempted the Brutal San Felipe 250
msn.com - April 7 at 2:22 PM
MultiStrat deploys $1.75bn in casualty ILS, announces series of key hiresMultiStrat deploys $1.75bn in casualty ILS, announces series of key hires
reinsurancene.ws - April 4 at 12:46 PM
MultiStrat targets “significant growth” after deploying $1.75bn in casualty ILSMultiStrat targets “significant growth” after deploying $1.75bn in casualty ILS
artemis.bm - April 3 at 2:02 PM
Dane Lopes joins AscotDane Lopes joins Ascot
royalgazette.com - April 2 at 5:54 PM
OUs Jalil Farooq creating chemistry with Jackson Arnold, striving to be the best version of me in 2024OU's Jalil Farooq creating chemistry with Jackson Arnold, striving to be the 'best version of me' in 2024
tulsaworld.com - April 2 at 12:52 PM
Catalan leader proposes new referendum for in dependence from SpainCatalan leader proposes new referendum for in dependence from Spain
dailysabah.com - April 2 at 12:52 PM
SEC football is all about trench warfare. Are the Sooners ready? Here’s what spring practice tells usSEC football is all about trench warfare. Are the Sooners ready? Here’s what spring practice tells us
tulsaworld.com - April 2 at 12:18 AM
Patricia Coffey is a forensic psychologist who loves learning about what makes you tickPatricia Coffey is a forensic psychologist who loves learning about what makes you tick
madison.com - April 1 at 7:18 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Charles River Laboratories International logo

Charles River Laboratories International

NYSE:CRL
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Everest Re Group logo

Everest Re Group

NYSE:RE
Everest Re Group, Ltd., through its subsidiaries, provides reinsurance and insurance products in the United States, Bermuda, and internationally. The company operates through Reinsurance Operations and Insurance Operations segments. The Reinsurance Operations segment writes property and casualty reinsurance; and specialty lines of business through reinsurance brokers, as well as directly with ceding companies in the United States, Bermuda, Ireland, Canada, Singapore, Switzerland, and the United Kingdom. The Insurance Operations segment writes property and casualty insurance directly, as well as through brokers, surplus lines brokers, and general agents in the United States, Bermuda, Canada, Europe, South America, France, Germany, Spain, Canada, Chile, the United Kingdom, Ireland, and the Netherlands. The company also provides treaty and facultative reinsurance products; admitted and non-admitted insurance products; and property and casualty reinsurance and insurance coverages, including marine, aviation, surety, errors and omissions liability, directors' and officers' liability, medical malpractice, mortgage reinsurance, other specialty lines, accident and health, and workers' compensation products. In addition, it offers commercial property and casualty insurance products through wholesale and retail brokers, surplus lines brokers, and program administrators. The company was founded in 1973 and is headquartered in Hamilton, Bermuda.